Breast Cancer
Breast cancer is a type of cancer that forms in the cells of the breasts, often presenting as a lump or mass. It can affect both men and women, though it is much more common in women.
We are studying the safety and early effectiveness of AZD8205, both alone and with other cancer treatments, for people with advanced or metastatic solid tumors. This research aims to find the best dose and understand how the drug works in the body.
Health conditions and diseases that the clinical trial is designed to study and treat.
Breast cancer is a type of cancer that forms in the cells of the breasts, often presenting as a lump or mass. It can affect both men and women, though it is much more common in women.
Ovarian cancer begins in the ovaries and can cause symptoms like abdominal bloating, pelvic pain, and changes in bowel habits. It is often diagnosed at a later stage.
Endometrial cancer starts in the lining of the uterus and is often associated with abnormal vaginal bleeding. It is the most common type of uterine cancer.
Biliary neoplasm refers to cancer that occurs in the bile ducts, which can lead to symptoms like jaundice, abdominal pain, and weight loss.
Non-small cell lung cancer is a type of lung cancer that is more common than small cell lung cancer. It can cause symptoms like a persistent cough, chest pain, and shortness of breath.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.